Markets Remain Volatile

Tue, 2 Feb 01:30 pm

   Previous Close   

   Pre-Open   

   09:30 am   

   11:30 am   

   Closing   

The Indian Equity markets were trading close to the dotted line in a volatile trade as Reserve Bank of India Governor Raghuram Rajan chose to keep the policy repo rate unchanged on inflation concerns. Sectoral indices are trading mixed with stocks from the IT sector leading the gains and metal sector leading the losses.

The BSE Sensex is trading down by 4 points and the NSE Nifty is trading down by 12 points. The S&P BSE Midcap> index is trading flat while the S&P BSE Small cap index is trading up by 0.2%. The rupee is trading at 67.67 to the US$.

According to an article in The Economic Times, Sun Pharmaceuticals launched a new drug called Imatinib Mesylate in the United States market. This product is a generic copy of anti- cancer drug Gleevec. Being a first-to-file product, the company will enjoy 180 days of marketing exclusivity by the US Food and Drug Administration (FDA).

Sun Pharma's subsidiary received final approval for Imatinib Mesylate from FDA in December 2015. Reports suggest that the six-month exclusivity could rake in US$300-400 million in sales for the company. The company also rolled out a savings card program to reduce out-of-pocket expenditures for patients to US$10 and offer savings benefits of up to US$700 for a 30-day fill.

Meanwhile, Dr Reddy's Laboratories has also reportedly received the US FDA approval for two new drugs in three days. Dr Reddy's Lab got the US regulator's tentative approval for skin treatment drug Zenavod just a couple of days after the company received FDA approval for anti-migraine injection Zembrace . While Zenavod is expected to launch in 2020, all attention seems to be on the anti migraine injection, which is reported to have a market size of nearly US$1.4 billion.

The approvals have come at a time when Indian drug companies are facing the FDA's ire for non- compliance of good manufacturing process (Subscription Required).

The stock of Dr Reddy's is currently trading up by 0.9% on the BSE.

Moving on to the news from power sector. India Ratings and Research (Ind-Ra) has maintained a 'stable to negative' outlook on the power sector for the next fiscal as the plant load factor (PLF) of plants is expected to remain low amid muted growth in electricity demand. The rating agency expects power demand to grow modestly at 4-5% and power generation at 5-6% in FY 2016-17, with deficits remaining low at 3-4%.

According to the reports, the muted demand growth is based on the expectation of stunted growth by industrial consumers which constitutes 40% of the energy sales. Moreover, the current focus on the use of efficient devices (LEDs and agricultural pumps) is leading to lower demand. The PLFs of the thermal power plants are likely to remain low as demand growth remains muted. Moreover, as the renewable energy share increases, it could exert additional pressure on the PLFs of coal-based plants.

The ratings agency, however, noted that the outlook could be revised to 'stable' on directional movement towards improvement in the financial health of discoms, better visibility on demand growth for electricity leading to improvements in PLFs.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers